Growth Opportunity Small to mid-sized biotechnology firm with revenue between 1M-10M and recent funding; potential for expanding diagnostics partnerships, co-development deals, and distribution agreements to accelerate market reach.

Diagnostics Expansion Strong focus on FISH probes and genomic diagnostics in oncology presents opportunities to cross-sell supplementary panels, controls, and custom assay development services to enhance customers' existing workflows.

Strategic Partnerships Recent collaboration with BioDot for hematology-focused probe panels indicates openness to automation-enabled solutions; target partnerships with instrumentation developers and automation platforms to bundle integrated workflows.

Global Reach Global distribution network suggests potential for regional channel partnerships, localized regulatory/commercial support, and co-marketing initiatives to accelerate adoption in underserved markets.

Innovation Roadmap Investment in website refresh and emphasis on precision medicine signals a readiness to scale product launches; propose pilot programs, early-access panels, and customer case studies to demonstrate value to prospective buyers.